EMD-61076

Single-particle
2.33 Å
EMD-61076
3D View Gallery
Deposition: 05/08/2024
Map released: 19/03/2025
Last modified: 19/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-61076

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9j1m summary report (pdf.gz) Map-9j1m FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

KU13-bond Mycobacterium tuberculosis 70S ribosome

EMD-61076

Single-particle
2.33 Å
EMD-61076
3D View Gallery
Deposition: 05/08/2024
Map released: 19/03/2025
Last modified: 19/03/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mycobacterium tuberculosis variant bovis BCG str. Pasteur 1173P2
Sample: KU13-bond Mycobacterium tuberculosis 70S ribosome
Fitted models: 9j1m

Deposition Authors: Nishihara D , Fujino M , Tanaka Y, Yokoyama T
Creation of a macrolide antibiotic against non-tuberculous Mycobacterium using late-stage boron-mediated aglycon delivery.
Isozaki Y , Makikawa T, Kimura K, Nishihara D , Fujino M , Tanaka Y, Hayashi C, Ishizaki Y, Igarashi M , Yokoyama T , Toshima K , Takahashi D
(2025) Sci Adv , 11 , eadt2352 - eadt2352
PUBMED: 40043128
DOI: doi:10.1126/sciadv.adt2352
ISSN: 2375-2548
Grant Support: